Neurodegenerative Disease Assay Kit

NDs are multifactorial complex disorders with genetics playing a crucial role in their development.

The challenge of their early detection and precise diagnosis is ever more pressing. Traditional diagnostic methods are often invasive, such as cerebrospinal fluid (CSF) sampling, or costly, such as PET scans.

Thus, the demand for a less invasive, blood-based test that can accurately diagnose NDs early, aid in drug development, and inform treatment choices is significant

Features and benefits

FIRST IN CLASS TEST

for the measurement of microRNAs in peripheral blood & plasma.

NCRNA BIOMARKERS

for the diagnostic of MCI, early Alzheimer's and other dementia types

INVESTIGATION OF A NOVEL CLASS

of therapeutic targets.

DIRECT INSIGHT OF BRAIN CONDITION

using blood without needing brain biopsies

Simplified workflow

Sample Preparation

RNA Extraction

RT-QPCR

Data Analysis

OPTIMIZE YOUR BIOMARKER PROJECTS AND DEVELOPMENT PROGRAMS

From concept to regulatory qualification, with significant experience in each step, we provide steadfast support across diverse areas

Design of biomarker program

and analytical development

Planning and study design

Development of SOPs

Standard Operating Procedures

Regulatory support

preparing dossiers and opinion meeting

Biomarker regulatory qualification

for IVD development